BGP Products Operations GmbH – a Viatris Company
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | SRC |
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | — |
| 02 Oct 2025 | Olivér Várhelyi Commissioner | All pressing portfolio topics | SRC |
| 26 Jun 2025 | Olivier Girard Head of Unit | Exchange of views on advancing the access and availability of medical countermeasures | SRC |
| 26 Jun 2025 | Olivier Girard Head of Unit | Exchange of views on advancing the access and availability of medical countermeasures | — |
| 05 Jun 2023 | Zaneta Vegnere Cabinet member | Trade & Technology Council, Global Steel and Aluminum Arrangement, Critical Minerals Agreement | SRC |
| 05 Jun 2023 | Zaneta Vegnere Cabinet member | Trade & Technology Council, Global Steel and Aluminum Arrangement, Critical Minerals Agreement | — |
Mission & Goals
Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, leveraging the strengths of both companies and approximately 38,000 colleagues worldwide. As one of the top three pharmaceutical companies in Europe, we are dedicated to increasing access to affordable, quality medicines for patients. Our diverse portfolio includes best-in-class, iconic brand-name products, generics (including branded and complex), and over-the-counter offerings across a wide range of therapeutic areas. In Europe, we rely on 10,000 dedicated employees to carry out all aspects of our business, including commercial operations, R&D, manufacturing, and packaging. We are committed to creating healthier communities through education, outreach, and better access to treatment. With strong EU infrastructure, we have a track record of providing a continuous, reliable supply of high-quality medicines, delivering over 36 billion doses annually across all 38 European countries.
EU Legislative Interests
Critical Medicines Act EU Pharmaceutical legislation Paediatric Regulation EU4Health Programme Access to Innovation Industrial Policy EU Trade Policy Health Systems Performance Assessment Health Technology Assessment Pharmaceuticals in the environment EU Pharmaceutical Strategy EU Industrial Strategy EU Chemical Strategy Access to Medicines Medicines Shortages Antimicrobial Resistance European Green Deal Lessons learned from COVID-19 Urban Waste-Water Treatment Directive Packaging and Packaging Waste Directive EHDS EU Global Health Strategy
Communication Activities
Viatris EU Twitter account: @ViatrisEUPolicy Viatris EU Policy website: https://www.viatrispolicy.eu/en
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Medicines for Europe (MfE) https://www.medicinesforeurope.com/ Amcham EU https://www.amchameu.eu/ Pharma Deutschland Brussels Office: https://www.pharmadeutschland.de/
Organisation Members
Inter-association Task Force on the Pharmaceuticals in the environment https://www.efpia.eu/about-medicines/development-of-medicines/regulations-safety-supply/pharmaceuticals-in-the-environment-pie/ Inter-association Task Force on Electronic Patients ´ Information Leaflet European Policy Centre